Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The term "viral and cellular DNA" collectively refers to the deoxyribonucleic acid molecules that carry genetic information in viruses (for DNA viruses) and in the cells of living organisms. Cellular DNA encodes the heritable instructions for life, while viral DNA forms the genome of DNA viruses, enabling their replication and hijacking of the host cell's machinery[3][5][8]. Cellular and viral DNAs are both composed of nucleotide polymers but differ in organization, coding capacity, and susceptibility to repair mechanisms[1][4]. Many antiviral and anticancer therapies act by targeting DNA or its replication/repair processes. However, since "viral and cellular DNA" is a broad descriptor for genetic material rather than a specific target, it is not considered a canonical drug target by itself[3][5][8].
Inhibition of DNA polymerase, Induction of DNA damage, Inhibition of DNA repair, Other
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Viral and cellular DNA.